The China Mail - DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025

USD -
AED 3.672498
AFN 63.999735
ALL 82.817919
AMD 366.961185
ANG 1.790403
AOA 917.499323
ARS 1477.241103
AUD 1.446343
AWG 1.8
AZN 1.697294
BAM 1.719513
BBD 2.008994
BDT 122.690487
BGN 1.69088
BHD 0.376969
BIF 2980
BMD 1
BND 1.294146
BOB 6.89258
BRL 5.194602
BSD 0.997508
BTN 94.112631
BWP 13.611387
BYN 2.838756
BYR 19600
BZD 2.006181
CAD 1.420175
CDF 2270.000042
CHF 0.80985
CLF 0.023384
CLP 920.329617
CNY 6.7905
CNH 6.80075
COP 3447.34
CRC 454.001969
CUC 1
CUP 26.5
CVE 96.940099
CZK 21.338897
DJF 177.630075
DKK 6.574405
DOP 58.781123
DZD 133.435974
EGP 49.519299
ERN 15
ETB 158.650208
EUR 0.879699
FJD 2.266097
FKP 0.75995
GBP 0.757575
GEL 2.64026
GGP 0.75995
GHS 11.218905
GIP 0.75995
GMD 72.467862
GNF 8740.757673
GTQ 7.610005
GYD 208.702762
HKD 7.84065
HNL 26.719771
HRK 6.622094
HTG 130.371712
HUF 311.819493
IDR 17967
ILS 2.982925
IMP 0.75995
INR 94.925034
IQD 1310
IRR 1375050.000244
ISK 126.659905
JEP 0.75995
JMD 157.214761
JOD 0.708991
JPY 161.781969
KES 129.56048
KGS 87.450005
KHR 4009.999521
KMF 433.999718
KPW 900.00035
KRW 1545.569951
KWD 0.30963
KYD 0.831256
KZT 483.438614
LAK 22065.000373
LBP 89328.533059
LKR 336.16866
LRD 181.540044
LSL 16.58951
LTL 2.95274
LVL 0.60489
LYD 6.405725
MAD 9.415501
MDL 17.705627
MGA 4252.569389
MKD 54.191762
MMK 2099.534862
MNT 3583.823146
MOP 8.055405
MRU 40.069873
MUR 48.190248
MVR 15.450344
MWK 1736.999903
MXN 17.498301
MYR 4.119901
MZN 63.898139
NAD 16.589665
NGN 1376.194249
NIO 36.610278
NOK 9.844901
NPR 150.579371
NZD 1.768695
OMR 0.384505
PAB 0.99749
PEN 3.421972
PGK 4.377508
PHP 61.33403
PKR 277.594113
PLN 3.7694
PYG 6095.373741
QAR 3.645016
RON 4.603399
RSD 103.226012
RUB 75.701185
RWF 1465.854892
SAR 3.754982
SBD 8.051953
SCR 13.627228
SDG 599.999843
SEK 9.734419
SGD 1.296904
SHP 0.746601
SLE 24.802674
SLL 20969.503664
SOS 570.059564
SRD 37.320126
STD 20697.981008
STN 21.540261
SVC 8.728411
SYP 110.532098
SZL 16.516625
THB 33.340336
TJS 9.221714
TMT 3.5
TND 2.937498
TOP 2.40776
TRY 46.561603
TTD 6.774893
TWD 31.826298
TZS 2618.978969
UAH 44.85287
UGX 3690.695456
UYU 40.019342
UZS 11982.22316
VES 620.752985
VND 26320
VUV 119.820737
WST 2.777776
XAF 576.690844
XAG 0.017281
XAU 0.000248
XCD 2.70255
XCG 1.797729
XDR 0.717231
XOF 576.698449
XPF 104.849947
YER 238.625005
ZAR 16.4766
ZMK 9001.201308
ZMW 18.004545
ZWL 321.999592
  • RBGPF

    0.0000

    61.3

    0%

  • RYCEF

    -0.1600

    18

    -0.89%

  • BCC

    2.1000

    79.76

    +2.63%

  • BCE

    0.0000

    23.2

    0%

  • CMSC

    -0.0190

    22.046

    -0.09%

  • VOD

    0.0500

    13.86

    +0.36%

  • GSK

    0.8000

    51.89

    +1.54%

  • NGG

    0.5900

    83.42

    +0.71%

  • RELX

    -0.2300

    30.92

    -0.74%

  • RIO

    1.0800

    95.11

    +1.14%

  • JRI

    0.0100

    12.58

    +0.08%

  • CMSD

    -0.0900

    21.93

    -0.41%

  • BTI

    1.0900

    62.48

    +1.74%

  • AZN

    2.6600

    185.68

    +1.43%

  • BP

    -0.1400

    37.72

    -0.37%

DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025
DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025

DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025

"For DEXIS, 2024 was a year of tremendous innovation, as we continue to provide dental professionals with the most powerful, efficient and time-saving diagnostic tools and technologies," DEXIS President Robert Befidi said. "We are proud of our progress and will bring that momentum with us in 2025 as we unveil exciting, industry-changing initiatives."

Text size:

QUAKERTOWN, PENNSYLVANIA / ACCESS Newswire / February 3, 2025 / DEXIS, an international leader in dental imaging technologies, celebrates the 2024 launch of its DEXIS digital ecosystem along with other AI-powered imaging solutions. The company also announces that 2025 will bring further innovations, with presentations at two major dental technology conferences.

The company enhanced its portfolio of award-winning imaging solutions in 2024, beginning with the February 2024 launch of the DEXIS digital ecosystem, a suite of tools and software designed to connect and streamline the implant workflow. The platform combines cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning to aid clinicians through their entire digital workflow from diagnosis to delivery. The open imaging system ensures that clinicians have the freedom to customize workflows and that patients, labs, and staff have the appropriate visibility, creating a seamless experience.

May 2024 brought the release of the DEXIS Ti2 Intraoral Sensor, built on the success of its predecessor, the best-selling DEXIS Titanium Sensor. The Ti2 sensor provides high-resolution images while also adding 2D AI Dental Findings, an integrated offering that automatically identifies and highlights 6 common dental findings. The sensor's housing also incorporates subtle design changes that make it more resistant to drops and wear.

In August, the company announced the launch of DEXIS™ Connect Pro, which provides proactive monitoring of DEXIS CBCT and intraoral sensor devices through IoT technology. It connects DEXIS customers with more than 100 DEXIS technical support agents, automatically arranging support, preventative maintenance, or equipment replacements if performance issues are detected. By keeping digital equipment operating without interruption, the Connect Pro solution enhances office productivity and consistent patient care for dental professionals who rely on DEXIS technology.

DEXIS continued to actively improve its solutions with the September 2024 release of the ORTHOPANTOMOGRAPH™ OP 3D™ EX X-ray platform. Designed specifically for general practitioners looking to expand their diagnostic capabilities with 3D imaging, the OP 3D EX has a wide range of field of view sizes to support multiple clinical indications. Updates to the DTX Studio™ Clinic software provided advanced tools and new functionality that allows practitioners to plan an implant treatment and generate a surgical guide chairside, in less than three minutes.

DEXIS envisions 2025 as another year of ground-breaking advancements in technology and customer service. Projects currently in production or development include:

  • The first intraoral scanner developed entirely by DEXIS

  • AI enhancements across the ecosystem to increase efficiency and productivity

  • An exciting innovation within the 3D imaging portfolio

  • Updates to enhance the implant workflow in DTX Studio Clinic

DEXIS expects to begin rolling out these initiatives at two major 2025 industry meetings: the Chicago Dental Society Midwinter Meeting in February and the International Dental Show in Cologne, Germany, in March.

The Chicago Dental Society meeting, February 20-25 at McCormick Place West, is the organization's 160th annual midwinter conference and offers more than 200 courses on dental medicine. It draws both U.S. and international dental professionals as well as hundreds of exhibitors.

The International Dental Show, March 25-29, is the world's leading trade fair for the dental sector. The biennial event is known as a trend-setting event, where major manufacturers unveil advances in technology for the top decision-makers in dentistry.

As one of the world's leading developers of dental imaging technologies, DEXIS sees both events as essential venues for showcasing its products and connecting with DEXIS owners." There are more than 150,000 DEXIS dental imaging devices in use worldwide which is a testament to our mission to transform practices and patient smiles globally," Befidi said. "Every year, we build on our long tradition of innovation and successes, learn from our lessons, and aim to provide innovative solutions and exceptional service to our customers."

Visit the company's website at www.dexis.com to stay informed about the latest industry news, product information, and upcoming events.

About DEXIS

DEXIS has been a global leading brand in digital radiography for 70+ years. Today, DEXIS has brought together the most trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software to provide you with a complete digital diagnostic solution under a brand name. Our innovative award-winning technology enhances the way you diagnose, accelerates your workflow, and delivers simpler treatment paths with better patient outcomes. For more information, please visit https://www.dexis.com.

About Envista Holdings Corporation
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide array of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.

Contact Information

Maria Penaloza
Media & Content Strategy Manager
[email protected]

Julie Hansoulle
Sr. Marketing Manager DEXIS EU
[email protected]

SOURCE: Envista



View the original press release on ACCESS Newswire

H.Ng--ThChM